conditions
18 guides
condition_hub
Addiction and Psychedelic-Assisted Therapy in Canada
Substance use disorders (SUDs) — alcohol use disorder (AUD), opioid use disorder (OUD), tobacco use disorder, cocaine use disorder, cannabis use disorder, and others — affect roughly 1 in 5 Canadians in their...
condition_hub
Anxiety Disorders and Psychedelic-Assisted Therapy in Canada
Anxiety disorders are the most prevalent mental health conditions in Canada — affecting roughly 1 in 4 Canadians at some point in life, with generalized anxiety disorder (GAD), panic disorder, social anxiety...
condition_hub
Bipolar Disorder and Psychedelic-Assisted Therapy — Safety Considerations
Bipolar disorder is a recurrent mood disorder characterized by episodes of mania (Bipolar I) or hypomania (Bipolar II) alternating with episodes of major depression. Bipolar disorder affects roughly 2.6% of Canadian...
condition_hub
Burnout, Moral Injury, and Psychedelic-Assisted Therapy in Canada
WHO ICD-11 (2019 revision) categorizes burnout as an "occupational phenomenon" (not a medical condition): Moral injury is the lasting psychological, biological, spiritual, behavioral, and social impact of...
condition_hub
Chronic Pain and Psychedelic-Assisted Therapy in Canada
Chronic pain — pain persisting beyond normal tissue healing time, typically defined as >3 months — affects roughly 1 in 5 Canadians (Statistics Canada CCHS; Public Health Agency of Canada). Specific syndromes include...
condition_hub
Concurrent Disorders, Dual Diagnosis, and Psychedelic-Assisted Therapy in Canada
The term "concurrent disorders" is Canadian (CCSA, CMHA usage); "dual diagnosis" is the U.S. equivalent. The term is used in two senses: Major concurrent disorder patterns: CRISM and ASAM guidance: integrated...
pillar_hub
Conditions Treated with Psychedelic-Assisted Therapy in Canada
This page covers seventeen conditions and answers the cross-condition questions that individual condition articles cannot. If you have arrived here from a search like "what conditions does psychedelic therapy treat"...
condition_hub
Eating Disorders and Psychedelic-Assisted Therapy in Canada
Eating disorders — anorexia nervosa (AN), bulimia nervosa (BN), binge eating disorder (BED), avoidant/restrictive food intake disorder (ARFID), and other specified feeding or eating disorders (OSFED) — affect roughly...
condition_hub
End-of-Life Distress and Psychedelic-Assisted Therapy in Canada
End-of-life distress is the constellation of emotional, existential, and psychological suffering experienced by patients facing life-limiting illness — characterized by demoralization, existential dread, anticipatory...
condition_hub
OCD and Psychedelic-Assisted Therapy — A Deep Dive
Obsessive-compulsive disorder (OCD) affects approximately 1–3% of Canadians across the lifespan and is now classified in DSM-5 within its own chapter — Obsessive-Compulsive and Related Disorders — distinct from the...
condition_hub
Panic Disorder and Psychedelic-Assisted Therapy in Canada
Panic disorder affects roughly 2–3% of Canadians in any given year, with lifetime prevalence closer to 5%. It is characterized by recurrent unexpected panic attacks alongside persistent worry about future attacks or...
condition_hub
Personality Disorders (BPD) and Psychedelic-Assisted Therapy — Considerations
Personality disorders (PDs) are a category of DSM-5 mental disorders characterized by enduring patterns of inner experience and behaviour that deviate markedly from cultural expectations, are pervasive and...
condition_hub
Postpartum Depression and Psychedelic-Assisted Therapy in Canada
Postpartum depression (PPD) is a major depressive episode with peripartum onset specifier (DSM-5) — onset during pregnancy or within 4 weeks postpartum (with most clinical and surveillance definitions extending the...
condition_hub
PTSD and Psychedelic-Assisted Therapy in Canada
Posttraumatic stress disorder (PTSD) is a DSM-5 diagnosis arising after exposure to actual or threatened death, serious injury, or sexual violence — characterized by intrusion symptoms, avoidance, negative...
condition_hub
Schizophrenia and Psychotic Disorders — Why Psychedelic-Assisted Therapy Is Generally Contraindicated
Schizophrenia and the broader family of psychotic disorders — schizoaffective disorder, schizophreniform disorder, brief psychotic disorder, delusional disorder, substance/medication-induced psychotic disorder, and...
condition_hub
Sleep Disorders, Insomnia, and Psychedelic-Assisted Therapy in Canada
Sleep disorders affect roughly one in three Canadian adults in any given year, with chronic insomnia disorder present in 10–15% of the population (Statistics Canada CCHS; Morin 2011 Canadian epidemiology). Clinical...
condition_hub
Suicidality and Psychedelic-Assisted Therapy in Canada
Suicidality is a clinical situation, not a diagnosis — it spans passive suicidal ideation ("I wish I weren't here"), active suicidal ideation with intent or plan, suicidal behavior including attempts, and the...
condition_hub
Treatment-Resistant Depression and Psychedelic-Assisted Therapy in Canada
Treatment-resistant depression (TRD) is the clinical situation where a patient with a major depressive disorder has failed to respond adequately to at least two trials of antidepressants from different...